Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients.

Hariri G, Bourcier S, Marjanovic Z, Joffre J, Lemarié J, Lavillegrand JR, Charue D, Duflot T, Bigé N, Baudel JL, Maury E, Mohty M, Guidet B, Bellien J, Blanc-Brude O, Ait-Oufella H.

Crit Care. 2019 Aug 30;23(1):292. doi: 10.1186/s13054-019-2572-9.

2.

Discovery of first in vivo active inhibitors of soluble epoxide hydrolase (sEH) phosphatase domain.

Kramer JS, Woltersdorf S, Duflot T, Hiesinger K, Lillich FF, Knöll F, Wittmann SK, Klingler FM, Brunst S, Chaikuad A, Morisseau C, Hammock BD, Buccellati C, Sala A, Rovati GE, Leuillier M, Fraineau S, Rondeaux J, Hernandez Olmos V, Heering J, Merk D, Pogoryelov D, Steinhilber D, Knapp S, Bellien J, Proschak E.

J Med Chem. 2019 Aug 22. doi: 10.1021/acs.jmedchem.9b00445. [Epub ahead of print]

PMID:
31436984
3.

Impact of the acute local inhibition of soluble epoxide hydrolase on diabetic skin microcirculatory dysfunction.

Savina Y, Duflot T, Bounoure F, Kotzki S, Thiebaut PA, Serreau PA, Skiba M, Picquenot JM, Cornic M, Morisseau C, Hammock B, Imbert L, Cracowski JL, Richard V, Roustit M, Bellien J.

Diab Vasc Dis Res. 2019 Jul 3:1479164119860215. doi: 10.1177/1479164119860215. [Epub ahead of print]

PMID:
31267765
4.

Endothelium-dependent adaptation of arterial wall viscosity during blood flow increase is impaired in essential hypertension.

Roca F, Bellien J, Iacob M, Joannides R.

Atherosclerosis. 2019 Jun;285:102-107. doi: 10.1016/j.atherosclerosis.2019.04.208. Epub 2019 Apr 8.

PMID:
31051413
5.

[Diuretic therapy].

Wils J, Dupuis G, Hemery T, Joannidès R, Bellien J.

Rev Prat. 2019 Jan;69(1):e19-e27. Review. French. No abstract available.

PMID:
30983303
6.

Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.

Duflot T, Moreau-Grangé L, Roche C, Iacob M, Wils J, Rémy-Jouet I, Cailleux AF, Leuillier M, Renet S, Li D, Morisseau C, Lamoureux F, Richard V, Prévost G, Joannidès R, Bellien J.

Cardiovasc Diabetol. 2019 Mar 18;18(1):35. doi: 10.1186/s12933-019-0843-z.

7.

Dipeptidyl Peptidase-4 Inhibition Prevents Vascular Calcification by Potentiating the Insulin-Like Growth Factor-1 Signaling Pathway.

Varennes O, Mary A, Bricca G, Kamel S, Bellien J.

JACC Basic Transl Sci. 2019 Feb 25;4(1):113-115. doi: 10.1016/j.jacbts.2018.11.002. eCollection 2019 Feb. No abstract available.

8.

Endothelium structure and function in kidney health and disease.

Jourde-Chiche N, Fakhouri F, Dou L, Bellien J, Burtey S, Frimat M, Jarrot PA, Kaplanski G, Le Quintrec M, Pernin V, Rigothier C, Sallée M, Fremeaux-Bacchi V, Guerrot D, Roumenina LT.

Nat Rev Nephrol. 2019 Feb;15(2):87-108. doi: 10.1038/s41581-018-0098-z. Review.

PMID:
30607032
9.

Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.

Wils J, Djerada Z, Roca F, Duflot T, Iacob M, Remy-Jouet I, Joannides R, Bellien J.

Atherosclerosis. 2018 Aug;275:239-245. doi: 10.1016/j.atherosclerosis.2018.06.865. Epub 2018 Jun 19.

PMID:
29980050
10.

[Cardiovascular consequences of chronic kidney disease, impact of modulation of epoxyeicosatrienoic acids].

Hamzaoui M, Guerrot D, Djerada Z, Duflot T, Richard V, Bellien J.

Ann Cardiol Angeiol (Paris). 2018 Jun;67(3):141-148. doi: 10.1016/j.ancard.2018.04.018. Epub 2018 May 22. Review. French.

PMID:
29793671
11.

Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.

Duflot T, Marie-Cardine A, Verstuyft C, Filhon B, Pereira T, Massy-Guillemant N, Joannidès R, Bellien J, Lamoureux F.

Fundam Clin Pharmacol. 2018 Jun;32(3):337-342. doi: 10.1111/fcp.12345. Epub 2018 Jan 25.

PMID:
29319893
12.

Generation of gene-edited rats by delivery of CRISPR/Cas9 protein and donor DNA into intact zygotes using electroporation.

Remy S, Chenouard V, Tesson L, Usal C, Ménoret S, Brusselle L, Heslan JM, Nguyen TH, Bellien J, Merot J, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Sci Rep. 2017 Nov 29;7(1):16554. doi: 10.1038/s41598-017-16328-y.

13.

Evidence for a Role of Vascular Endothelium in the Control of Arterial Wall Viscosity in Humans.

Roca F, Iacob M, Remy-Jouet I, Bellien J, Joannides R.

Hypertension. 2018 Jan;71(1):143-150. doi: 10.1161/HYPERTENSIONAHA.117.09870. Epub 2017 Nov 20.

PMID:
29158357
14.

Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".

Bellien J, Kamel S.

Circulation. 2017 Oct 24;136(17):1670-1671. doi: 10.1161/CIRCULATIONAHA.117.029883. No abstract available.

PMID:
29061581
15.

Impact of CYP3A4 Genotype on Voriconazole Exposure.

Duflot T, Schrapp A, Bellien J, Lamoureux F.

Clin Pharmacol Ther. 2018 Feb;103(2):185-186. doi: 10.1002/cpt.809. Epub 2017 Aug 29. No abstract available.

PMID:
28786228
16.

Multiple and Opposite Effects of Angiotensin II Receptor Blockers on the Bioavailability of Epoxyeicosatrienoic Acids.

Bellien J, Leuillier M, Louhichi S, Duflot T, Joannides R.

Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):213-214. doi: 10.1111/bcpt.12810. Epub 2017 Jun 22. No abstract available.

17.

Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors.

Bellien J, Iacob M, Monteil C, Rémy-Jouet I, Roche C, Duflot T, Vendeville C, Gutierrez L, Thuillez C, Richard V, Joannidès R.

J Hypertens. 2017 Jun;35(6):1204-1212. doi: 10.1097/HJH.0000000000001307.

PMID:
28441692
18.

A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.

Duflot T, Pereira T, Roche C, Iacob M, Cardinael P, Hamza NE, Thuillez C, Compagnon P, Joannidès R, Lamoureux F, Bellien J.

Anal Bioanal Chem. 2017 Mar;409(7):1845-1855. doi: 10.1007/s00216-016-0129-1. Epub 2016 Dec 15.

PMID:
27981341
19.

Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.

Wils J, Favre J, Bellien J.

Pharmacol Ther. 2017 Feb;170:98-115. doi: 10.1016/j.pharmthera.2016.10.014. Epub 2016 Oct 20. Review.

PMID:
27773788
20.

[Characteristics and predictive factors of success in critical reading exam among medical students. School of Medicine, Rouen (France), 2012-2013].

Ladner J, Tavolacci MP, Joly LM, Lequerré T, Benhamou Y, Savoye-Collet C, Bellien J, Brasse Lagnel C, Coeffier M, Benichou J, Veber B.

Presse Med. 2016 Jan;45(1):142-4. doi: 10.1016/j.lpm.2015.10.011. Epub 2015 Nov 17. French. No abstract available.

PMID:
26597585
21.

Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice.

Roche C, Guerrot D, Harouki N, Duflot T, Besnier M, Rémy-Jouet I, Renet S, Dumesnil A, Lejeune A, Morisseau C, Richard V, Bellien J.

Prostaglandins Other Lipid Mediat. 2015 Jul;120:148-54. doi: 10.1016/j.prostaglandins.2015.04.011. Epub 2015 May 27.

22.

The authors reply.

Lorthioir A, Bellien J.

Kidney Int. 2015 Apr;87(4):857. doi: 10.1038/ki.2014.421. No abstract available.

PMID:
25826545
23.

Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.

Roche C, Besnier M, Cassel R, Harouki N, Coquerel D, Guerrot D, Nicol L, Loizon E, Remy-Jouet I, Morisseau C, Mulder P, Ouvrard-Pascaud A, Madec AM, Richard V, Bellien J.

Am J Physiol Heart Circ Physiol. 2015 May 1;308(9):H1020-9. doi: 10.1152/ajpheart.00465.2014. Epub 2015 Feb 27.

24.

Editorial: renal endothelial dysfunction: evolving concepts and perspectives.

Guerrot D, Bellien J.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):1-2. No abstract available.

PMID:
25088123
25.

Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome.

Benhamou Y, Bellien J, Armengol G, Brakenhielm E, Adriouch S, Iacob M, Remy-Jouet I, Le Cam-Duchez V, Monteil C, Renet S, Jouen F, Drouot L, Menard JF, Borg JY, Thuillez C, Boyer O, Levesque H, Richard V, Joannidès R.

Arthritis Rheumatol. 2014 Nov;66(11):3210-20. doi: 10.1002/art.38785.

26.

Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans.

Lorthioir A, Joannidès R, Rémy-Jouet I, Fréguin-Bouilland C, Iacob M, Roche C, Monteil C, Lucas D, Renet S, Audrézet MP, Godin M, Richard V, Thuillez C, Guerrot D, Bellien J.

Kidney Int. 2015 Feb;87(2):465-72. doi: 10.1038/ki.2014.241. Epub 2014 Jul 16.

PMID:
25029430
27.

Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.

Duflot T, Roche C, Lamoureux F, Guerrot D, Bellien J.

Expert Opin Drug Discov. 2014 Mar;9(3):229-43. doi: 10.1517/17460441.2014.881354. Epub 2014 Feb 4. Review.

PMID:
24490654
28.

[Assessment of endothelial function in autoimmune diseases].

Benhamou Y, Bellien J, Armengol G, Gomez E, Richard V, Lévesque H, Joannidès R.

Rev Med Interne. 2014 Aug;35(8):512-23. doi: 10.1016/j.revmed.2013.12.010. Epub 2014 Jan 10. Review. French.

PMID:
24412013
29.

High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.

Bellien J, Fréguin-Bouilland C, Joannidès R, Hanoy M, Rémy-Jouet I, Monteil C, Iacob M, Martin L, Renet S, Vendeville C, Godin M, Thuillez C, Le Roy F.

Nephrol Dial Transplant. 2014 Feb;29(2):414-22. doi: 10.1093/ndt/gft448. Epub 2013 Nov 13.

PMID:
24235073
30.

Impaired role of epoxyeicosatrienoic acids in the regulation of basal conduit artery diameter during essential hypertension.

Bellien J, Remy-Jouet I, Iacob M, Blot E, Mercier A, Lucas D, Dreano Y, Gutierrez L, Donnadieu N, Thuillez C, Joannides R.

Hypertension. 2012 Dec;60(6):1415-21. doi: 10.1161/HYPERTENSIONAHA.112.201087. Epub 2012 Oct 22.

PMID:
23090775
31.

Epoxyeicosatrienoic acid pathway in human health and diseases.

Bellien J, Joannides R.

J Cardiovasc Pharmacol. 2013 Mar;61(3):188-96. doi: 10.1097/FJC.0b013e318273b007. Review.

PMID:
23011468
32.

Diabetic CVD--soluble epoxide hydrolase as a target.

Lorthioir A, Guerrot D, Joannides R, Bellien J.

Cardiovasc Hematol Agents Med Chem. 2012 Sep;10(3):212-22. Review.

PMID:
22632263
33.

Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.

Bellien J, Iacob M, Remy-Jouet I, Lucas D, Monteil C, Gutierrez L, Vendeville C, Dreano Y, Mercier A, Thuillez C, Joannides R.

Circulation. 2012 Mar 13;125(10):1266-75. doi: 10.1161/CIRCULATIONAHA.111.070680.

PMID:
22412088
34.

Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.

Merabet N, Bellien J, Glevarec E, Nicol L, Lucas D, Remy-Jouet I, Bounoure F, Dreano Y, Wecker D, Thuillez C, Mulder P.

J Mol Cell Cardiol. 2012 Mar;52(3):660-6. doi: 10.1016/j.yjmcc.2011.11.015. Epub 2011 Dec 6.

PMID:
22155238
35.

Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine.

Joannidès R, Monteil C, de Ligny BH, Westeel PF, Iacob M, Thervet E, Barbier S, Bellien J, Lebranchu Y, Seguin SG, Thuillez C, Godin M, Etienne I.

Am J Transplant. 2011 Nov;11(11):2414-22. doi: 10.1111/j.1600-6143.2011.03697.x. Epub 2011 Sep 19.

36.

Mechanical and structural characteristics of carotid plaques by combined analysis with echotracking system and MR imaging.

Beaussier H, Naggara O, Calvet D, Joannides R, Guegan-Massardier E, Gerardin E, Iacob M, Laloux B, Bozec E, Bellien J, Touze E, Masson I, Thuillez C, Oppenheim C, Boutouyrie P, Laurent S.

JACC Cardiovasc Imaging. 2011 May;4(5):468-77. doi: 10.1016/j.jcmg.2011.01.017.

37.

Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?

Bellien J, Joannides R, Richard V, Thuillez C.

Pharmacol Ther. 2011 Jul;131(1):1-17. doi: 10.1016/j.pharmthera.2011.03.015. Epub 2011 Apr 14. Review.

PMID:
21514320
38.

Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in mice with renovascular hypertension.

Gao J, Bellien J, Gomez E, Henry JP, Dautreaux B, Bounoure F, Skiba M, Thuillez C, Richard V.

J Hypertens. 2011 Jun;29(6):1128-35. doi: 10.1097/HJH.0b013e328345ef7b.

PMID:
21451419
39.

Protective effect of mycophenolate mofetil on endothelial function in an aortic allograft model.

Fréguin-Bouilland C, Godin M, Bellien J, Richard V, Remy-Jouet I, Dautreaux B, Henry JP, Compagnon P, Thuillez C, Plissonnier D, Joannidès R.

Transplantation. 2011 Jan 15;91(1):35-41. doi: 10.1097/TP.0b013e3181fe12d6.

PMID:
21441851
40.

Comparative effects of sirolimus and cyclosporin on conduit arteries endothelial function in kidney recipients.

Joannides R, Etienne I, Iacob M, Hurault de Ligny B, Barbier S, Bellien J, Lebranchu Y, Thuillez C, Godin M.

Transpl Int. 2010 Nov;23(11):1135-43. doi: 10.1111/j.1432-2277.2010.01122.x.

41.

Hypertrophic remodeling and increased arterial stiffness in patients with intracranial aneurysms.

Maltete D, Bellien J, Cabrejo L, Iacob M, Proust F, Mihout B, Thuillez C, Guegan-Massardier E, Joannides R.

Atherosclerosis. 2010 Aug;211(2):486-91. doi: 10.1016/j.atherosclerosis.2010.04.002. Epub 2010 Apr 13.

PMID:
20452592
42.

Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes.

Bellien J, Costentin A, Dutheil-Maillochaud B, Iacob M, Kuhn JM, Thuillez C, Joannides R.

Diab Vasc Dis Res. 2010 Apr;7(2):158-66. doi: 10.1177/1479164109360470. Epub 2010 Feb 22.

PMID:
20382780
43.

Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans.

Bellien J, Favre J, Iacob M, Gao J, Thuillez C, Richard V, Joannidès R.

Hypertension. 2010 Mar;55(3):674-80. doi: 10.1161/HYPERTENSIONAHA.109.142190. Epub 2010 Jan 18.

PMID:
20083732
44.

Commentaries on viewpoint: pick your Poiseuille: normalizing the shear stimulus in studies of flow-mediated dilation.

Joannidès R, Bellien J.

J Appl Physiol (1985). 2009 Oct;107(4):1363; author reply 1366. doi: 10.1152/japplphysiol.00748.2009. No abstract available.

45.

Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans.

Bellien J, Thuillez C, Joannides R.

Fundam Clin Pharmacol. 2008 Aug;22(4):363-77. doi: 10.1111/j.1472-8206.2008.00610.x. Review.

PMID:
18705747
46.

Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration.

Joannides R, Bellien J, Thurlure C, Iacob M, Abeel M, Thuillez C.

Am J Hypertens. 2008 Jun;21(6):679-84. doi: 10.1038/ajh.2008.39. Epub 2008 Apr 3.

PMID:
18443573
47.

Role of endothelium-derived hyperpolarizing factor in the regulation of radial artery basal diameter and endothelium-dependent dilatation in vivo.

Bellien J, Thuillez C, Joannides R.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):494-7. doi: 10.1111/j.1440-1681.2008.04903.x.

PMID:
18307748
48.

AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.

Bellien J, Iacob M, Eltchaninoff H, Bourkaib R, Thuillez C, Joannides R.

Clin Sci (Lond). 2007 Jun;112(7):393-401.

PMID:
17125466
49.

Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation.

Bellien J, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C, Joannides R.

Hypertension. 2006 Dec;48(6):1088-94. Epub 2006 Oct 30.

PMID:
17075035
50.

Clinical methods for the evaluation of endothelial function-- a focus on resistance arteries.

Joannides R, Bellien J, Thuillez C.

Fundam Clin Pharmacol. 2006 Jun;20(3):311-20. Review.

PMID:
16671967

Supplemental Content

Loading ...
Support Center